|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
90,552,000 |
Market
Cap: |
2.99(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$18.07 - $59.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 8 |
Insider 3/6 Months : 8.6 |
|
Guru Rank Number : 538 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile PTC Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. Co. has the following products, Translarna (ataluren) and Emflaza® (deflazacort), for the treatment of Duchenne muscular dystrophy, a rare, life threatening disorder. Co.'s gene therapy product candidates for rare monogenic diseases that affect the central nervous system (CNS) include PTC- Aromatic L-Amino Acid Decarboxylase (AADC) for the treatment of AADC deficiency, a rare CNS disorder arising from reductions in the enzyme AADC that results from mutations in the dopa decarboxylase gene.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
7,700 |
7,700 |
7,700 |
Total Buy Value |
$0 |
$198,736 |
$198,736 |
$198,736 |
Total People Bought |
0 |
1 |
1 |
1 |
Total Buy Transactions |
0 |
1 |
1 |
1 |
Total Shares Sold |
5,981 |
52,172 |
114,858 |
280,340 |
Total Sell Value |
$151,224 |
$1,447,501 |
$4,819,149 |
$12,887,777 |
Total People Sold |
3 |
8 |
10 |
15 |
Total Sell Transactions |
4 |
26 |
35 |
88 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Southwell David P |
|
|
2023-03-27 |
4 |
OE |
$27.05 |
$270,500 |
D/D |
10,000 |
20,500 |
|
- |
|
Utter Christine Marie |
SVP, FINANCE & CAO |
|
2023-03-27 |
4 |
AS |
$44.71 |
$1,202,106 |
D/D |
(26,658) |
38,059 |
|
-15% |
|
Utter Christine Marie |
SVP, FINANCE & CAO |
|
2023-03-27 |
4 |
OE |
$33.02 |
$880,247 |
D/D |
26,658 |
47,788 |
|
- |
|
Peltz Stuart Walter |
CHIEF EXECUTIVE OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$13,734 |
I/I |
(301) |
54,903 |
|
6% |
|
Peltz Stuart Walter |
CHIEF EXECUTIVE OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$105,857 |
D/D |
(2,320) |
166,962 |
|
6% |
|
Utter Christine Marie |
SVP, FINANCE & CAO |
|
2023-01-31 |
4 |
S |
$45.63 |
$14,829 |
D/D |
(325) |
38,059 |
|
6% |
|
Pauwels Eric |
CHIEF BUSINESS OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$17,111 |
D/D |
(375) |
65,537 |
|
6% |
|
Hill Emily Luisa |
CHIEF FINANCIAL OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$26,236 |
D/D |
(575) |
46,288 |
|
6% |
|
Boulding Mark Elliott |
EXEC. VP AND CLO |
|
2023-01-31 |
4 |
S |
$45.63 |
$37,050 |
D/D |
(812) |
75,378 |
|
6% |
|
Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$1,278 |
I/I |
(28) |
3,259 |
|
6% |
|
Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
|
2023-01-31 |
4 |
S |
$45.63 |
$28,746 |
D/D |
(630) |
63,949 |
|
6% |
|
Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
|
2023-01-24 |
4 |
S |
$47.45 |
$2,088 |
I/I |
(44) |
3,287 |
|
7% |
|
Pauwels Eric |
CHIEF BUSINESS OFFICER |
|
2023-01-24 |
4 |
S |
$47.45 |
$17,035 |
D/D |
(359) |
65,912 |
|
7% |
|
Peltz Stuart Walter |
CHIEF EXECUTIVE OFFICER |
|
2023-01-24 |
4 |
S |
$47.45 |
$13,476 |
I/I |
(284) |
55,204 |
|
7% |
|
Hill Emily Luisa |
CHIEF FINANCIAL OFFICER |
|
2023-01-24 |
4 |
S |
$47.45 |
$10,582 |
D/D |
(223) |
46,863 |
|
7% |
|
Klein Matthew B. |
CHIEF OPERATING OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$99,543 |
D/D |
(2,244) |
77,856 |
|
-29% |
|
Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$1,198 |
I/I |
(27) |
3,331 |
|
-29% |
|
Almstead Neil Gregory |
CHIEF TECHNICAL OPS OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$16,990 |
D/D |
(383) |
64,579 |
|
-29% |
|
Hill Emily Luisa |
CHIEF FINANCIAL OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$18,542 |
D/D |
(418) |
47,086 |
|
-29% |
|
Utter Christine Marie |
SVP, FINANCE & CAO |
|
2023-01-11 |
4 |
S |
$44.36 |
$18,498 |
D/D |
(417) |
38,384 |
|
-29% |
|
Boulding Mark Elliott |
EXEC. VP AND CLO |
|
2023-01-11 |
4 |
S |
$44.36 |
$21,958 |
D/D |
(495) |
76,190 |
|
-29% |
|
Pauwels Eric |
CHIEF BUSINESS OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$25,329 |
D/D |
(571) |
66,271 |
|
-29% |
|
Peltz Stuart Walter |
CHIEF EXECUTIVE OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$21,825 |
I/I |
(492) |
55,488 |
|
-29% |
|
Peltz Stuart Walter |
CHIEF EXECUTIVE OFFICER |
|
2023-01-11 |
4 |
S |
$44.36 |
$52,744 |
D/D |
(1,189) |
169,282 |
|
-29% |
|
Klein Matthew B. |
CHIEF OPERATING OFFICER |
|
2023-01-10 |
4 |
S |
$42.93 |
$97,586 |
D/D |
(2,273) |
80,100 |
|
-32% |
|
564 Records found
|
|
Page 4 of 23 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|